The campaign runs from August 25 to September 8 and links public awareness with hospital-based retrieval and regional eye-bank coordination. For ocular biobanking, the relevant variable is not pledge volume alone. It is the conversion of post-mortem consent into viable tissue within a narrow retrieval window.
The supply gap is a throughput problem
The campaign is being conducted against an estimated 1.1 million cases of corneal blindness in India. Reported annual transplant activity remains between 25,000 and 30,000 procedures, constrained by donor-tissue availability.
That gap indicates a failure across several pipeline stages: family consent, notification, retrieval routing, tissue assessment, preservation, allocation, and surgical scheduling. Awareness campaigns address the first stages, but they do not automatically increase usable tissue throughput. Every additional donor pledge still requires a functioning hospital interface and a retrieval team capable of acting after death.
AIIMS Delhi is presented as a higher-performing institutional node. Its National Eye Bank reportedly collected 1,931 corneas through a Hospital Corneal Retrieval Programme in the past year and performed more than 1,000 transplant surgeries annually. The reported tissue-utilization rate was 85 percent, above the national average.
That figure is operationally significant. Utilization measures the proportion of retrieved tissue that reaches a transplant pathway rather than being rejected, diverted, or lost during evaluation and processing. It therefore reflects more than donor recruitment. It captures coordination quality, screening capacity, preservation handling, and matching efficiency.
Retrieval latency remains the critical variable
The reported medical guidance is that harvesting should occur within six to eight hours after death, provided the cornea remains viable. This creates a hard logistical constraint. A pledge recorded months or years earlier has limited value if the family does not know whom to contact, the hospital does not escalate the notification, or the retrieval network cannot reach the site in time.
AIIMS has reportedly expanded its retrieval network across Delhi, while The Times of India reported the addition of three hospitals to that network. The operational objective is decentralization: move notification and retrieval closer to the point of death, reducing transport delay and dependence on a single central facility.
Haryana authorities are also reported to have established a dedicated 112 emergency routing system for families seeking rapid post-mortem tissue harvesting. Such systems can reduce procurement latency, but their performance depends on call handling, dispatch coverage, retrieval staffing, and documentation. The available reports do not provide failure rates or response-time data.
The campaign is also addressing a common screening misconception. Reports from the initiative state that age, previous refractive surgery, hypertension, or diabetes do not automatically exclude a donor. Final suitability is determined through medical evaluation of the donated corneal tissue. This distinction matters for intake operations: broad public eligibility messaging can increase notifications, while the eye bank retains responsibility for quality control and recipient safety.
What the network needs to demonstrate
National Eye Donation Fortnight places public attention on the front end of the tissue pipeline. The more consequential test will come after the campaign period: whether awareness converts into measurable increases in consent, retrieval, viable-tissue yield, utilization, and transplant capacity.
AIIMS’s reported 85 percent utilization rate provides a benchmark, but not yet a national performance standard. The expansion of hospital links and emergency routing may improve geographic coverage, while rural vision-center training is intended to strengthen access to primary eye care before reversible conditions progress to permanent blindness.
For researchers and biobanking planners, the key indicators to track are straightforward: retrieval volume by hospital, interval from death notification to procurement, rejection causes, preservation performance, and tissue utilization by processing site. Without those data, campaign reach remains an awareness metric rather than evidence of improved biospecimen flow.
The current evidence supports a narrow conclusion. India is attempting to increase corneal availability by combining demand generation with distributed retrieval infrastructure. Whether that reduces the shortage will depend less on the number of pledges than on the reliability of the cold-chain, notification, and allocation pipeline that follows them.